title: Effects of long-term primidone and phenytoin administration on canine hepatic function and morphology.
abstract: Primidone, phenytoin, or phenytoin and primidone in combination were given to healthy Beagle dogs for 6 months. Serum biochemical changes in dogs given primidone alone or phenytoin and primidone in combination for the entire 6-month test period included increased activities of alanine aminotransferase, alkaline phosphatase (AP), and gamma-glutamyltransferase, and decreased concentrations of albumin and cholesterol. Changes in dogs given phenytoin alone were limited to increased AP activity and decreased albumin concentration. Sulfobromophthalein excretion and conjugated bile acid concentration were within normal limits. All dogs given primidone alone or phenytoin alone remained clinically healthy throughout the treatment period. Three of 8 dogs given both drugs in combination became clinically ill after 9, 14, and 15 weeks of treatment, and were euthanatized. Two of the dogs developed clinical jaundice. In addition to the serum biochemical abnormalities observed in clinically healthy dogs, these dogs developed hyperbilirubinemia, delayed sulfobromophthalein excretion, and increased conjugated bile acid concentrations. Histologic examination of the liver showed intracanalicular casts of bile pigment typical of intrahepatic cholestasis in all 3 dogs. Histologic findings characteristic of treated dogs included hepatocellular hypertrophy attributable to hyperplasia of the smooth endoplasmic reticulum. Single-cell necrosis and multifocal lipidosis were observed in individuals of all treatment groups. Electron microscopy of the liver showed dilated bile canaliculi and damaged sinusoidal epithelium in dogs given both drugs. The elevated serum AP activity, associated with anticonvulsant drug therapy, was found to be exclusively the liver isoenzyme by cellulose acetate electrophoresis. The hepatic AP was localized to primarily the canalicular membranes by enzyme histochemistry. There was a statistically significant positive correlation between the AP activities of liver and serum. The results of this study indicate that long-term administration of anticonvulsant drugs to dogs is associated with clinical, serum biochemical, and histologic evidence of hepatic dysfunction. High drug dosage contributed most to abnormal serum biochemical test results, and combining phenytoin with primidone was responsible for more severe electron microscopic lesions of the liver of surviving dogs and for the death of 3 dogs.
authors.forename: S E
authors.initials: SE
authors.lastname: Bunch
authors.forename: W L
authors.initials: WL
authors.lastname: Castleman
authors.forename: B H
authors.initials: BH
authors.lastname: Baldwin
authors.forename: W E
authors.initials: WE
authors.lastname: Hornbuckle
authors.forename: B C
authors.initials: BC
authors.lastname: Tennant
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D002784:Cholesterol / Q000097:blood; D004285:Dogs / Q000033:anatomy & histology / Q000502:physiology*; D004338:Drug Combinations; D005260:Female; D008099:Liver / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D008854:Microscopy, Electron; D010672:Phenytoin / Q000008:administration & dosage / Q000494:pharmacology*; D011324:Primidone / Q000008:administration & dosage / Q000494:pharmacology*; D012709:Serum Albumin / Q000378:metabolism; D013997:Time Factors; D005723:gamma-Glutamyltransferase / Q000097:blood
chemical_list: D004338:Drug Combinations; D012709:Serum Albumin; D011324:Primidone; D010672:Phenytoin; D002784:Cholesterol; D005723:gamma-Glutamyltransferase; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase